- Home
- NVO vs CRWD Comparison
NVO vs CRWD Comparison
Compare NVO & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | CRWD |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | Denmark | United States |
| Employees | 69500 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.4B | 165.5B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | NVO | CRWD |
|---|---|---|
| Price | $42.90 | $675.88 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 48 |
| Target Price | $51.00 | ★ $507.00 |
| AVG Volume (30 Days) | ★ 10.9M | 3.5M |
| Earning Date | 05-06-2026 | 06-02-2026 |
| Dividend Yield | ★ 3.19% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,812,005,000.00 |
| Revenue This Year | N/A | $24.85 |
| Revenue Next Year | $3.70 | $21.40 |
| P/E Ratio | ★ $13.60 | $6,543.36 |
| Revenue Growth | N/A | ★ 21.71 |
| 52 Week Low | $35.12 | $342.72 |
| 52 Week High | $81.44 | $785.66 |
Technical Indicators
Market Signals| Indicator | NVO | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 46.75 | 59.78 |
| Support Level | $35.49 | $477.12 |
| Resistance Level | $50.30 | N/A |
| Average True Range (ATR) | 1.15 | 33.86 |
| MACD | -0.45 | 0.09 |
| Stochastic Oscillator | 27.11 | 46.13 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.